S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
$28.82
+0.8%
$30.01
$28.25
$37.65
$70.81B0.534.97 million shs3.62 million shs
Lixte Biotechnology Holdings, Inc. stock logo
LIXT
Lixte Biotechnology
$3.41
+2.4%
$2.77
$1.58
$9.50
$7.67M-0.28474,777 shs18,311 shs
NMC Health plc stock logo
NMHLY
NMC Health
$0.00
$0.00
$0.00
$0.18
N/A-5.2616,591 shs100 shs
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
$1.71
-2.8%
$1.87
$0.97
$5.10
$7.32M0.5929,818 shs6,766 shs
Xcelerate Inc. stock logo
XCRT
Xcelerate
$0.04
$0.04
$0.03
$0.14
$16.21M2.73102,072 shs240,045 shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
+0.72%-1.94%-8.00%-2.64%-19.37%
Lixte Biotechnology Holdings, Inc. stock logo
LIXT
Lixte Biotechnology
-4.86%-0.89%+35.92%+92.49%-51.10%
NMC Health plc stock logo
NMHLY
NMC Health
0.00%0.00%0.00%0.00%-92.00%
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
+0.86%-6.12%+2.62%-14.73%-58.13%
Xcelerate Inc. stock logo
XCRT
Xcelerate
+5.03%+0.71%-15.18%-31.93%-15.88%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
1.1737 of 5 stars
0.03.02.50.03.00.01.3
Lixte Biotechnology Holdings, Inc. stock logo
LIXT
Lixte Biotechnology
N/AN/AN/AN/AN/AN/AN/AN/A
NMC Health plc stock logo
NMHLY
NMC Health
N/AN/AN/AN/AN/AN/AN/AN/A
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
0.989 of 5 stars
3.53.00.00.00.00.00.0
Xcelerate Inc. stock logo
XCRT
Xcelerate
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
2.67
Moderate BuyN/AN/A
Lixte Biotechnology Holdings, Inc. stock logo
LIXT
Lixte Biotechnology
N/AN/AN/AN/A
NMC Health plc stock logo
NMHLY
NMC Health
N/AN/AN/AN/A
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
3.00
Buy$10.00484.80% Upside
Xcelerate Inc. stock logo
XCRT
Xcelerate
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
$33.94B2.09$19.09 per share1.51$26.80 per share1.08
Lixte Biotechnology Holdings, Inc. stock logo
LIXT
Lixte Biotechnology
N/AN/AN/AN/A$0.22 per shareN/A
NMC Health plc stock logo
NMHLY
NMC Health
N/AN/AN/AN/AN/AN/A
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
$4.91M1.49N/AN/A($0.30) per share-5.70
Xcelerate Inc. stock logo
XCRT
Xcelerate
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
-$17.87BN/A0.005.641.18N/AN/AN/AN/A
Lixte Biotechnology Holdings, Inc. stock logo
LIXT
Lixte Biotechnology
-$5.09M-$2.70N/AN/AN/A-1,202.60%-119.91%5/8/2024 (Estimated)
NMC Health plc stock logo
NMHLY
NMC Health
N/AN/A0.00N/AN/AN/AN/AN/A
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
-$13.32M-$33.76N/AN/AN/A-271.04%-805.57%-97.73%4/18/2024 (Estimated)
Xcelerate Inc. stock logo
XCRT
Xcelerate
N/AN/A0.00N/AN/AN/AN/AN/A

Latest NMHLY, PSTV, LIXT, XCRT, and BTI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/19/2024Q4 2023
Lixte Biotechnology Holdings, Inc. stock logo
LIXT
Lixte Biotechnology
N/A-$0.41-$0.41-$0.41N/AN/A
3/5/2024Q4 2023
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
-$0.78-$0.70+$0.08-$0.70$1.26 million$1.31 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
$2.9310.17%+1.97%N/A1 Years
Lixte Biotechnology Holdings, Inc. stock logo
LIXT
Lixte Biotechnology
N/AN/AN/AN/AN/A
NMC Health plc stock logo
NMHLY
NMC Health
$0.2098,000.00%N/AN/AN/A
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
N/AN/AN/AN/AN/A
Xcelerate Inc. stock logo
XCRT
Xcelerate
N/AN/AN/AN/AN/A

Latest NMHLY, PSTV, LIXT, XCRT, and BTI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/14/2024
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
quarterly$0.74319.6%12/20/202412/20/20242/6/2025
2/13/2024
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
quarterly$0.74319.6%12/20/202412/20/20242/6/2025
2/12/2024
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
quarterly$0.74319.5%6/28/20246/28/20248/7/2024
2/8/2024
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
Quarterly$0.73309.53%3/21/20243/22/20245/7/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
0.67
0.91
0.59
Lixte Biotechnology Holdings, Inc. stock logo
LIXT
Lixte Biotechnology
N/A
13.72
13.72
NMC Health plc stock logo
NMHLY
NMC Health
N/AN/AN/A
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
N/A
0.92
0.92
Xcelerate Inc. stock logo
XCRT
Xcelerate
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
21.44%
Lixte Biotechnology Holdings, Inc. stock logo
LIXT
Lixte Biotechnology
5.10%
NMC Health plc stock logo
NMHLY
NMC Health
N/A
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
3.28%
Xcelerate Inc. stock logo
XCRT
Xcelerate
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
46,0002.46 billion2.46 billionOptionable
Lixte Biotechnology Holdings, Inc. stock logo
LIXT
Lixte Biotechnology
32.25 million1.90 millionNot Optionable
NMC Health plc stock logo
NMHLY
NMC Health
17,748N/AN/ANot Optionable
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
204.28 million4.18 millionNot Optionable
Xcelerate Inc. stock logo
XCRT
Xcelerate
24434.45 millionN/ANot Optionable

NMHLY, PSTV, LIXT, XCRT, and BTI Headlines

SourceHeadline
Xcelerate, Inc. Engages Leading Investor Relations Firm Darrow Associates to Enhance Capital Markets PresenceXcelerate, Inc. Engages Leading Investor Relations Firm Darrow Associates to Enhance Capital Markets Presence
accesswire.com - March 25 at 8:30 AM
Xcelerate, Inc. Announces Participation in The Microcap ConferenceXcelerate, Inc. Announces Participation in The Microcap Conference
finance.yahoo.com - January 19 at 8:12 AM
Xcelerate, Inc. Announces Publication of its Two Utility Patent ApplicationsXcelerate, Inc. Announces Publication of its Two Utility Patent Applications
finance.yahoo.com - October 24 at 12:22 PM
Xcelerate, Inc. Announces that ESN Group, Inc. Has Been Approved as a Vendor to Army & Air Force Exchange ServiceXcelerate, Inc. Announces that ESN Group, Inc. Has Been Approved as a Vendor to Army & Air Force Exchange Service
stockhouse.com - September 14 at 10:17 AM
Xcelerate, Inc. Announces that ESN Group, Inc. Has Been  Approved as a Vendor to Army & Air Force Exchange ServiceXcelerate, Inc. Announces that ESN Group, Inc. Has Been Approved as a Vendor to Army & Air Force Exchange Service
finance.yahoo.com - September 14 at 10:17 AM
Xcelerate, Inc.: Xcelerate Announces Marketing AgreementXcelerate, Inc.: Xcelerate Announces Marketing Agreement
finanznachrichten.de - August 8 at 8:58 AM
Xcelerate Announces Marketing AgreementXcelerate Announces Marketing Agreement
finance.yahoo.com - August 8 at 8:58 AM
Xcelerate, Inc. Acquires a Majority Interest in ESN GroupXcelerate, Inc. Acquires a Majority Interest in ESN Group
finance.yahoo.com - July 25 at 10:54 AM
Xcelerate, Inc. Announces PTO and PCT Filings For Surgical DevicesXcelerate, Inc. Announces PTO and PCT Filings For Surgical Devices
finance.yahoo.com - April 20 at 8:46 AM
Xcelerate, Inc. Announces Agreement to Acquire a Controlling Interest in ESN, Inc.Xcelerate, Inc. Announces Agreement to Acquire a Controlling Interest in ESN, Inc.
finance.yahoo.com - April 12 at 10:44 AM
Xcelerate, Inc.: Xcelerate Announces that Afya Sasa Signs Agreement with the National Hospital of TanzaniaXcelerate, Inc.: Xcelerate Announces that Afya Sasa Signs Agreement with the National Hospital of Tanzania
finanznachrichten.de - March 14 at 6:59 PM
Xcelerate Announces that Afya Sasa Signs Agreement with the National Hospital of TanzaniaXcelerate Announces that Afya Sasa Signs Agreement with the National Hospital of Tanzania
finance.yahoo.com - March 14 at 6:59 PM
Fabian Urquijo Joins the Advisory Board of Xcelerate, Inc.Fabian Urquijo Joins the Advisory Board of Xcelerate, Inc.
finance.yahoo.com - February 1 at 9:53 AM
Xcelerate, Inc.: Xcelerate Inc. to Acquire Controlling Interest in ESN Group, IncXcelerate, Inc.: Xcelerate Inc. to Acquire Controlling Interest in ESN Group, Inc
finanznachrichten.de - January 17 at 11:21 AM
Xcelerate to acquire controlling interest in ESN GroupXcelerate to acquire controlling interest in ESN Group
seekingalpha.com - January 17 at 11:21 AM
Xcelerate Inc. to Acquire Controlling Interest in ESN Group, IncXcelerate Inc. to Acquire Controlling Interest in ESN Group, Inc
finance.yahoo.com - January 17 at 11:21 AM
Xcelerate, Inc. Releases Message from CEOXcelerate, Inc. Releases Message from CEO
finance.yahoo.com - January 3 at 11:46 AM
Xcelerate Inc: Spanning divide between engineering advancements and application to clinical careXcelerate Inc: Spanning divide between engineering advancements and application to clinical care
proactiveinvestors.com - August 31 at 6:26 PM
Xcelerate, Inc. to Develop Consumer Healthcare ProductsXcelerate, Inc. to Develop Consumer Healthcare Products
finance.yahoo.com - August 30 at 11:19 AM
Xcelerate, Inc.: Additional Countries Add Patent ProtectionXcelerate, Inc.: Additional Countries Add Patent Protection
finanznachrichten.de - August 24 at 7:03 PM
Additional Countries Add Patent ProtectionAdditional Countries Add Patent Protection
finance.yahoo.com - August 23 at 6:51 PM
Xcelerate Inc. (XCRT)Xcelerate Inc. (XCRT)
finance.yahoo.com - August 16 at 6:26 PM
Love Island’s Luca Bish slammed again for ‘over-reacting’Love Island’s Luca Bish slammed again for ‘over-reacting’
yahoo.com - August 3 at 6:35 PM
Delaware masking guidance changes as all three counties have high spread of COVIDDelaware masking guidance changes as all three counties have 'high' spread of COVID
yahoo.com - August 2 at 10:28 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

British American Tobacco logo

British American Tobacco

NYSE:BTI
British American Tobacco p.l.c. engages in the provision of tobacco and nicotine products to consumers worldwide. It also offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company offers its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Camel, Natural American Spirit, Newport, Vogue, Viceroy, Kool, Peter Stuyvesant, Craven A, State Express 555 and Shuang Xi brands. It also distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.
Lixte Biotechnology logo

Lixte Biotechnology

NASDAQ:LIXT
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to design novel compounds for serious common diseases. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically active drugs, which include the LB-100 series that consists of novel structures for the treatment of cancers, and vascular and metabolic diseases; and LB-200 series to treat chronic hereditary diseases, such as Gaucher's disease, as well as cancer and neurodegenerative diseases. Lixte Biotechnology Holdings, Inc. has a clinical trial research agreement with the Moffitt Cancer Center and Research Institute Hospital Inc.; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group, as well as Netherlands Cancer Institute and Oncode Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.
NMC Health logo

NMC Health

OTCMKTS:NMHLY
NMC Health plc provides healthcare services in the United Arab Emirates, the United Kingdom, Spain, and internationally. The company owns and manages healthcare facilities, including hospitals, medical centers, long term care facilities, day surgery centers, fertility clinics, and home health services providers. The company offers medical services comprising diagnostic, and in and outpatient services, as well as research and medical services in the field of gynecology, obstetrics, and human reproduction; and management services in respect of hospitals, as well as retails pharmaceutical goods. NMC Health plc was founded in 1974 and is based in London, United Kingdom.
Plus Therapeutics logo

Plus Therapeutics

NASDAQ:PSTV
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. Its lead drug candidate is Rhenium-186Re obisbemeda, a patented radiotherapy that targets central nervous system cancers and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. The company also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere that is designed to treat various solid organ cancers comprising primary and secondary liver cancers by intra-arterial injection. It has license agreements with NanoTx, Corp. and The University of Texas Health Science Center at San Antonio. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.
Xcelerate logo

Xcelerate

OTCMKTS:XCRT
Xcelerate Inc. acquires engineering/patents and applies to early-stage medical technology companies. The company engages in the formulation, packaging and marketing of consumer health and beauty, and clinically tested skin care products; development of artificial intelligence and virtual health technology to assist patients; owning and licensing the rights to various forms of medical equipment. It also provides Ceramedx, a natural plant based therapeutic skin care product; Earth Science Beauty, which offers natural facial skincare targeted to specific skin types. The company was formerly known as Union Dental Holdings, Inc. and changed its name to Xcelerate Inc. Xcelerate Inc. was incorporated in 1996 is based in Mauldin, South Carolina.